Skip to main content
Top
Published in: Sleep and Breathing 3/2005

01-09-2005 | Original Article

Sleep symptoms and clinical markers of illness in patients with heart failure

Authors: Karem Príncipe-Rodríguez, Kingman P. Strohl, Selma Hadziefendic, Ileana L. Piña

Published in: Sleep and Breathing | Issue 3/2005

Login to get access

Abstract

The purpose of this study was to survey patients with heart failure (HF) for sleep symptoms using a standardized questionnaire and correlate symptoms with conventional markers of clinical status. A self-report paper questionnaire was offered to patients presenting to a tertiary care HF clinic. Symptoms were grouped according to “risk” categories and correlated with routine clinical information. One hundred six (52.7% of 201 with all data) respondents had a high pretest probability for sleep apnea syndrome. Sixty three (31.3%) reported symptoms suggesting the presence of chronic insomnia; seven (3.5%) and eight (4%) reported symptoms of narcolepsy and restless legs syndrome, respectively. High-risk respondents for sleep apnea had a higher body mass index (p<0.001), were younger (p<0.05), and had a higher ejection fraction (p<0.05). The odds ratio (confidence interval) for paroxysmal nocturnal dyspnea (PND) to a complaint of sleepiness was 1.99 (1.1–3.6) and to a complaint of insomnia was 3.5 (1.8–6.5). In men, complaints of sleepiness in patients with PND were correlated, 4.47 (1.9–10.3), as was a correlation to high pretest probability for sleep apnea, 2.47 (1.1–5.5). There were no correlation of New York Heart Association status classification to high risk for sleep apnea, but a complaint of insomnia tended to occur with worsening functional status (p<0.05). There was only modest correlation of self-reported symptoms as elicited by a questionnaire and risk for sleep disorders with common clinical assessments for HF. Such collection of symptoms might be useful in establishing guidelines for routine sleep testing or as an adjunct to clinical trials.
Literature
1.
go back to reference Francos GC, Schairer HL Jr (2003) Hypertension. Contemporary challenges in geriatric care. Geriatrics 58(1):44–49; quiz 50PubMed Francos GC, Schairer HL Jr (2003) Hypertension. Contemporary challenges in geriatric care. Geriatrics 58(1):44–49; quiz 50PubMed
2.
go back to reference Volpe M, Rao MA, Tritto C, Pisani A, Mele AF, Enea I et al (1995) Transition from asymptomatic left ventricular dysfunction to congestive heart failure. J Card Fail 1(5):409–419PubMedCrossRef Volpe M, Rao MA, Tritto C, Pisani A, Mele AF, Enea I et al (1995) Transition from asymptomatic left ventricular dysfunction to congestive heart failure. J Card Fail 1(5):409–419PubMedCrossRef
3.
go back to reference Ghio S, Magrini G, Monti L (2003) The current therapeutic approach to chronic heart failure. Ital Heart J 4(Suppl 2):7S–14SPubMed Ghio S, Magrini G, Monti L (2003) The current therapeutic approach to chronic heart failure. Ital Heart J 4(Suppl 2):7S–14SPubMed
4.
go back to reference National Center for Health Statistics (1995) Detailed diagnoses and procedures, National Hospital Discharge Survey, 1993. Department of Health and Human Services Publication #95-1783, Hyattsville, MD National Center for Health Statistics (1995) Detailed diagnoses and procedures, National Hospital Discharge Survey, 1993. Department of Health and Human Services Publication #95-1783, Hyattsville, MD
5.
go back to reference O’Connell JB, Bristow MR (1994) Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13:S107–S112PubMed O’Connell JB, Bristow MR (1994) Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13:S107–S112PubMed
6.
go back to reference Fonarow GC (2001) The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med 2(Suppl 2):S7–S12CrossRefPubMed Fonarow GC (2001) The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med 2(Suppl 2):S7–S12CrossRefPubMed
7.
go back to reference Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMed Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMed
8.
go back to reference Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed
10.
go back to reference Ohayon MM, Guilleminault C, Paiva T, Priest RG, Rapoport DM, Sagales T et al (1997) An international study on sleep disorders in the general population: methodological aspects of the use of the Sleep-EVAL system. Sleep 20(12):1086–1092PubMed Ohayon MM, Guilleminault C, Paiva T, Priest RG, Rapoport DM, Sagales T et al (1997) An international study on sleep disorders in the general population: methodological aspects of the use of the Sleep-EVAL system. Sleep 20(12):1086–1092PubMed
11.
go back to reference Baldwin CM, Griffith KA, Nieto FJ, O’Connor GT, Walsleben JA, Redline S (2001) The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 24(1):96–105PubMed Baldwin CM, Griffith KA, Nieto FJ, O’Connor GT, Walsleben JA, Redline S (2001) The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 24(1):96–105PubMed
12.
go back to reference Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF et al (2000) Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 48(2):115–123PubMed Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF et al (2000) Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 48(2):115–123PubMed
13.
go back to reference Kapur VK, Redline S, Nieto FJ, Young TB, Newman AB, Henderson JA (2002) The relationship between chronically disrupted sleep and healthcare use. Sleep 25(3):289–296PubMed Kapur VK, Redline S, Nieto FJ, Young TB, Newman AB, Henderson JA (2002) The relationship between chronically disrupted sleep and healthcare use. Sleep 25(3):289–296PubMed
14.
go back to reference Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG et al (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154(1):50–59CrossRefPubMed Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG et al (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154(1):50–59CrossRefPubMed
15.
go back to reference Trinder J, Merson R, Rosenberg JI, Fitzgerald F, Kleiman J, Douglas Bradley T (2000) Pathophysiological interactions of ventilation, arousals, and blood pressure oscillations during Cheyne–Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 162(3 Pt 1):808–813PubMed Trinder J, Merson R, Rosenberg JI, Fitzgerald F, Kleiman J, Douglas Bradley T (2000) Pathophysiological interactions of ventilation, arousals, and blood pressure oscillations during Cheyne–Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 162(3 Pt 1):808–813PubMed
16.
go back to reference Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT (2003) Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123(4):1119–1126CrossRefPubMed Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT (2003) Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123(4):1119–1126CrossRefPubMed
17.
go back to reference Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290(14):1906–1914PubMedCrossRef Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290(14):1906–1914PubMedCrossRef
18.
go back to reference Krachman SL, Crocetti J, Berger TJ, Chatila W, Eisen HJ, D’Alonzo GE (2003) Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne–Stokes respiration and congestive heart failure. Chest 123(1):59–66CrossRefPubMed Krachman SL, Crocetti J, Berger TJ, Chatila W, Eisen HJ, D’Alonzo GE (2003) Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne–Stokes respiration and congestive heart failure. Chest 123(1):59–66CrossRefPubMed
19.
go back to reference Granton JT, Naughton MT, Benard DC, Liu PP, Goldstein RS, Bradley TD (1996) CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 153(1):277–282PubMed Granton JT, Naughton MT, Benard DC, Liu PP, Goldstein RS, Bradley TD (1996) CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 153(1):277–282PubMed
20.
go back to reference Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD (1995) Treatment of congestive heart failure and Cheyne–Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151(1):92–97PubMed Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD (1995) Treatment of congestive heart failure and Cheyne–Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151(1):92–97PubMed
21.
go back to reference Yasuma F, Ogihara A (2001) Long-term treatment of ischemic dilated cardiomyopathy with continuous positive airway pressure. Intern Med 40(11):1121–1127PubMedCrossRef Yasuma F, Ogihara A (2001) Long-term treatment of ischemic dilated cardiomyopathy with continuous positive airway pressure. Intern Med 40(11):1121–1127PubMedCrossRef
22.
go back to reference Leung RS, Bradley TD (1999) Long term treatment of refractory congestive heart failure by continuous positive airway pressure. Can J Cardiol 15(9):1009–1012PubMed Leung RS, Bradley TD (1999) Long term treatment of refractory congestive heart failure by continuous positive airway pressure. Can J Cardiol 15(9):1009–1012PubMed
23.
go back to reference Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne–Stokes respiration. Circulation 102(1):61–66PubMed Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne–Stokes respiration. Circulation 102(1):61–66PubMed
24.
go back to reference Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMedCrossRef Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMedCrossRef
25.
go back to reference Midelton GT, Frishman WH, Passo SS (2002) Congestive heart failure and continuous positive airway pressure therapy: support of a new modality for improving the prognosis and survival of patients with advanced congestive heart failure. Heart Dis 4(2):102–109CrossRefPubMed Midelton GT, Frishman WH, Passo SS (2002) Congestive heart failure and continuous positive airway pressure therapy: support of a new modality for improving the prognosis and survival of patients with advanced congestive heart failure. Heart Dis 4(2):102–109CrossRefPubMed
26.
go back to reference Seftel AD, Strohl KP, Loye TL, Bayard D, Kress J, Netzer NC (2002) Erectile dysfunction and symptoms of sleep disorders. Sleep 25(6):643–647PubMed Seftel AD, Strohl KP, Loye TL, Bayard D, Kress J, Netzer NC (2002) Erectile dysfunction and symptoms of sleep disorders. Sleep 25(6):643–647PubMed
27.
go back to reference Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131(7):485–491PubMed Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131(7):485–491PubMed
28.
go back to reference Yamashiro Y, Kryger MH (1993) Review: sleep in heart failure. Sleep 16(6):513–523PubMed Yamashiro Y, Kryger MH (1993) Review: sleep in heart failure. Sleep 16(6):513–523PubMed
29.
go back to reference Netzer NC, Hoegel JJ, Loube D, Netzer CM, Hay B, Alvarez-Sala R et al (2003) Prevalence of symptoms and risk of sleep apnea in primary care. Chest 124(4):1406–1414CrossRefPubMed Netzer NC, Hoegel JJ, Loube D, Netzer CM, Hay B, Alvarez-Sala R et al (2003) Prevalence of symptoms and risk of sleep apnea in primary care. Chest 124(4):1406–1414CrossRefPubMed
30.
go back to reference Hanly P, Zuberi-Khokhar N (1995) Daytime sleepiness in patients with congestive heart failure and Cheyne–Stokes respiration. Chest 107(4):952–958PubMedCrossRef Hanly P, Zuberi-Khokhar N (1995) Daytime sleepiness in patients with congestive heart failure and Cheyne–Stokes respiration. Chest 107(4):952–958PubMedCrossRef
31.
go back to reference Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault CC (2001) SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 63:49–55PubMed Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault CC (2001) SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 63:49–55PubMed
32.
go back to reference Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne–Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276PubMed Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne–Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276PubMed
33.
go back to reference Findley LJ, Zwillich CW, Ancoli-Israel S, Kripke D, Tisi G, Moser KM (1985) Cheyne-strokes breathing during sleep in patients with left venticular heart failure. South Med J 78(1):11–15PubMed Findley LJ, Zwillich CW, Ancoli-Israel S, Kripke D, Tisi G, Moser KM (1985) Cheyne-strokes breathing during sleep in patients with left venticular heart failure. South Med J 78(1):11–15PubMed
34.
go back to reference Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF et al (1999) Prognostic value of nocturnal Cheyne–Stokes respiration in chronic heart failure. Circulation 99(11):1435–1440PubMed Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF et al (1999) Prognostic value of nocturnal Cheyne–Stokes respiration in chronic heart failure. Circulation 99(11):1435–1440PubMed
35.
go back to reference Akosah KO, Schaper AM, Havlik P, Barnhart S, Devine S (2002) Improving care for patients with chronic heart failure in the community: the importance of a disease management program. Chest 122(3):906–912CrossRefPubMed Akosah KO, Schaper AM, Havlik P, Barnhart S, Devine S (2002) Improving care for patients with chronic heart failure in the community: the importance of a disease management program. Chest 122(3):906–912CrossRefPubMed
36.
go back to reference Xuan J, Duong PT, Russo PA, Lacey MJ, Wong B (2000) The economic burden of congestive heart failure in a managed care population. Am J Manag Care 6(6):693–700PubMed Xuan J, Duong PT, Russo PA, Lacey MJ, Wong B (2000) The economic burden of congestive heart failure in a managed care population. Am J Manag Care 6(6):693–700PubMed
37.
go back to reference Holst DP, Kaye D, Richardson M, Krum H, Prior D, Aggarwal A et al (2001) Improved outcomes from a comprehensive management system for heart failure. Eur J Heart Fail 3(5):619–625CrossRefPubMed Holst DP, Kaye D, Richardson M, Krum H, Prior D, Aggarwal A et al (2001) Improved outcomes from a comprehensive management system for heart failure. Eur J Heart Fail 3(5):619–625CrossRefPubMed
38.
go back to reference Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR et al (2003) A randomized controlled trial of adaptive ventilation for Cheyne–Stokes breathing in heart failure. Am J Respir Crit Care Med 168(9):1109–1114CrossRefPubMed Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR et al (2003) A randomized controlled trial of adaptive ventilation for Cheyne–Stokes breathing in heart failure. Am J Respir Crit Care Med 168(9):1109–1114CrossRefPubMed
39.
go back to reference Floras JS (2003) Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177(3):391–398CrossRefPubMed Floras JS (2003) Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177(3):391–398CrossRefPubMed
40.
go back to reference Bradley TD, Tkacova R, Hall MJ, Ando S, Floras JS (2003) Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. Clin Sci (Lond) 104(3):231–238CrossRef Bradley TD, Tkacova R, Hall MJ, Ando S, Floras JS (2003) Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. Clin Sci (Lond) 104(3):231–238CrossRef
41.
go back to reference Blankfield RP (2002) Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients. Sleep Breath 6(4):181–187CrossRefPubMed Blankfield RP (2002) Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients. Sleep Breath 6(4):181–187CrossRefPubMed
42.
go back to reference Whitney CW, Enright PL, Newman AB, Bonekat W, Foley D, Quan SF (1998) Correlates of daytime sleepiness in 4,578 elderly persons: the Cardiovascular Health Study. Sleep 21(1):27–36PubMed Whitney CW, Enright PL, Newman AB, Bonekat W, Foley D, Quan SF (1998) Correlates of daytime sleepiness in 4,578 elderly persons: the Cardiovascular Health Study. Sleep 21(1):27–36PubMed
43.
go back to reference Boland LL, Shahar E, Iber C, Knopman DS, Kuo TF, Nieto FJ (2002) Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 11(3):265–272CrossRefPubMed Boland LL, Shahar E, Iber C, Knopman DS, Kuo TF, Nieto FJ (2002) Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 11(3):265–272CrossRefPubMed
Metadata
Title
Sleep symptoms and clinical markers of illness in patients with heart failure
Authors
Karem Príncipe-Rodríguez
Kingman P. Strohl
Selma Hadziefendic
Ileana L. Piña
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 3/2005
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-005-0023-0

Other articles of this Issue 3/2005

Sleep and Breathing 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine